Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023
Net Sales ₹30 Cr₹26 Cr₹26 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹30 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹30 Cr
Mar2024₹26 Cr
Mar2023₹26 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2025 ₹30 Cr
19.16
Mar2024 ₹26 Cr
0.00
Mar2023 ₹26 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹73.6 Cr 2.3% 13.6% -34.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,022.4 Cr -3.2% 1.1% 1.6% Stock Analytics
KIRI INDUSTRIES ₹2,723.8 Cr 0.3% -2.3% -15.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,518.1 Cr -6.3% -3.2% -30.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,017.3 Cr -12.4% -5.9% 2.7% Stock Analytics
BODAL CHEMICALS ₹591.3 Cr -1.3% 1.2% -18.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

2.3%

13.6%

-34.8%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses